They went on to describe that gene therapy with A1AT delivered by rAAV8 prolongs lifespan in NZM2410 mice which develop spontaneous lupus with early-onset glomerulonephritis and that the protection was associated with reduced autoantibody levels (197). The gene discussed is SERPINA1; the disease is systemic lupus erythematosus.